![Thomson Reuters](https://static.lse.co.uk/images/news-logos/thomson-reuters-news-logo.png)
Sanofi profit slips on generic competition and currency effects
April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.
Read more